MedTrace Logo

Advanced Spatiomotor Rehabilitation for Navigation in Blindness & Visual Impairment

NCT05377853 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-11-22

No results posted yet for this study

Summary

One of the most challenging tasks for blind and visually impaired individuals is navigation through a complex environment. The goal of the present multidisciplinary study is to increase spatial-cognition abilities in people who are blind or visually impaired through training with the previously-developed Cognitive-Kinesthetic Rehabilitation Training to improve navigation, and to investigate the resultant neuroplastic brain reorganization through multimodal brain imaging.

In accordance with National Eye Institute (NEI) strategic goals, this multidisciplinary project will promote the development of well-informed new approaches to navigational rehabilitation, memory enhancement and cross-modal brain plasticity to benefit 'cutting edge' fields of mobile assistive technologies, vision restoration and memory facilitation for the aging brain.

Conditions

  • Blindness
  • Blindness, Acquired
  • Low Vision
  • Blindness, Complete

Interventions

BEHAVIORAL

Cognitive-Kinesthetic Navigational Training

Training with tactile maps to improve spatial memory capability for enhanced navigational capabilities.

Sponsors & Collaborators

  • Smith-Kettlewell Eye Research Institute

    lead OTHER

Principal Investigators

  • Lora T Likova · Senior Scientist

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377853 on ClinicalTrials.gov